According to a release issued by Ranbaxy to the BSE today, Pseudoephedrine Hydrochloride extended-release tablets is prescribed for temporary relief of nasal congestion due to common cold, hay fever or other respiratory allergies and nasal congestion associated with sinusitis.
"We are delighted to receive yet another USFDA approval this year. The tablets will be commercialised by Ohm Laboratories," Venkat Krishna, vice president of Ranbaxy Inc, said.
